Internal Medicine, Critical Care Medicine · Riverside, CA
NPI
1730376179
Since 2007
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
4100 Central Ave, Ste 201
Riverside, CA, 92506
Phone (951) 268-8840
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
3,039 services
Medicare patients, 2024
441
Average age 74
Drug cost, 2024
$719K
1,153 prescriptions
Company payments, 2025
$596
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aimee N French was code 99309 (snf e&m), 1,033 times for 25 patients. In total Aimee N French billed 3,039 services in 20 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 1,033 | 25 | $85.95 | $89K |
| 99214 Office E&M - Established | Office | 555 | 326 | $104.80 | $58K |
| 94727 Pulmonary Function Testing | Office | 375 | 317 | $35.32 | $13K |
| 94729 Pulmonary Function Testing | Office | 375 | 317 | $45.48 | $17K |
| 94060 Pulmonary Function Testing | Office | 374 | 317 | $30.50 | $11K |
| 99215 Office E&M - Established | Office | 92 | 69 | $145.57 | $13K |
| 94618 Pulmonary Function Testing | Office | 57 | 57 | $27.91 | $1,591 |
| 94010 Pulmonary Function Testing | Office | 41 | 40 | $22.90 | $939 |
| 99204 Office E&M - New | Office | 33 | 33 | $136.50 | $4,505 |
| 99306 SNF E&M | Facility | 16 | 11 | $146.03 | $2,337 |
| 99406 Behavioral Health Services | Office | 15 | 13 | $14.94 | $224 |
| 94664 E&M - Miscellaneous | Office | 12 | 11 | $15.28 | $183 |
By year: 2022 $412K for 4,825 services; 2023 $144K for 2,323 services; 2024 $215K for 3,039 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aimee N French prescribed most often to Medicare patients was Montelukast Sodium, with 182 prescriptions and refills. In total Aimee N French wrote 1,153 Medicare prescriptions that cost $719K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 182 | 279 | 70 | $1,597 |
| Levalbuterol Hcl Generic | 88 | 88 | Under 11 | $5,750 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 74 | 79 | 46 | $2,045 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 65 | 75 | 27 | $47K |
| Azithromycin Generic | 50 | 66 | 36 | $548 |
| Prednisone Generic | 42 | 42 | 28 | $180 |
| Ipratropium Bromide Generic | 40 | 40 | Under 11 | $1,303 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 33 | 39 | 19 | $24K |
| Glycopyrrolate Generic | 33 | 33 | Under 11 | $1,192 |
| Budesonide Generic | 32 | 32 | Under 11 | $8,153 |
| Scopolamine Generic | 28 | 28 | Under 11 | $3,252 |
| Azelastine Hcl Generic | 26 | 32 | Under 11 | $640 |
| Atropine Sulfate Generic | 24 | 24 | Under 11 | $1,267 |
| Arformoterol Tartrate Generic | 18 | 18 | Under 11 | $5,857 |
| Methylprednisolone Generic | 18 | 18 | 17 | $93.22 |
Brand drugs: 291 claims; generic drugs: 862 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aimee N French $596 ($596 in general payments such as food, travel and fees) from 8 companies. The largest payer was GlaxoSmithKline, LLC. with $186.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 13 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $158 |
| Insmed, Inc. INSM | 4 | $86.31 |
| Verona Pharma, Inc. VRNA | 2 | $63.92 |
| United Therapeutics Corporation UTHR | 1 | $34.59 |
| Liquidia Technologies, Inc. | 1 | $33.33 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.74 |
| Electromed, Inc. ELMD | 2 | $16.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.